Original Article | Published:

Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial

Molecular Psychiatry volume 22, pages 7681 (2017) | Download Citation

Abstract

Repeated drug consumption may progress to problematic use by triggering neuroplastic adaptations that attenuate sensitivity to natural rewards while increasing reactivity to craving and drug cues. Converging evidence suggests a single sub-anesthetic dose of the N-methyl-D-aspartate receptor antagonist ketamine may work to correct these neuroadaptations and restore motivation for non-drug rewards. Using an established laboratory model aimed at evaluating behavioral shifts in the salience of cocaine now vs money later, we found that ketamine, as compared to the control, significantly decreased cocaine self-administration by 67% relative to baseline at greater than 24 h post-infusion, the most robust reduction observed to date in human cocaine users and the first to involve mechanisms other than stimulant or dopamine agonist effects. These findings signal new directions in medication development for substance use disorders.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , . The brain on drugs: from reward to addiction. Cell 2015; 162: 712–725.

  2. 2.

    , . Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 2008; 33: 166–180.

  3. 3.

    , . Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159: 1642–1652.

  4. 4.

    , , , , . The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers. Biol Psychiatry 2014; 76: 40–46.

  5. 5.

    , , , , . Effect of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforces in mice. Behav Pharmacol 2003; 14: 237–244.

  6. 6.

    , , , , . The effects of memantine on the subjective, reinforcing, and cardiovascular effects of cocaine in human. Behav Pharmacol 1998; 9: 587–598.

  7. 7.

    , , , , , et al. D-cycloserine and cocaine cue reactivity: preliminary findings. Am J Drug Alcohol Abuse 2009; 35: 434–438.

  8. 8.

    , , , , , et al. A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period. Drug Alcohol Depend 2010; 111: 97–104.

  9. 9.

    , , , , , et al. A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. Eur J Neurosci 2007; 26: 757.

  10. 10.

    , , , , . Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 2008; 33: 761–768.

  11. 11.

    , . Agonist replacement for stimulant dependence: a review of clinical research. Curr Pharm Des 2013; 19: 7026–7035.

  12. 12.

    , , , , , . The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend 2008; 96: 1–15.

  13. 13.

    , , , , , et al. Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review. Ther Adv Chronic Dis 2015; 6: 97–114.

  14. 14.

    , , , , , et al. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol 2014; 17: 331–336.

  15. 15.

    , , , , , et al. BDNF Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex. Biol Psychiatry 2010; 71: 996–1005.

  16. 16.

    , , , , , et al. Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol Psychiatry 2009; 65: 289–295.

  17. 17.

    , , , , , et al. Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action. PloS One 2012; 7: e44799.

  18. 18.

    , , , . Structured Clinical Interview for DSM-IV-TR Axis I Disorders Clinical Trials Version (SCID-CT). Biometrics Research, New York State Psychiatric Institute: New York, 2007.

  19. 19.

    . A structured interview guide for the Hamilton Depression Scale. Arch Gen Psychiatry 1988; 45: 742–747.

  20. 20.

    , . Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis 1986; 174: 727–735.

  21. 21.

    , , , , , . Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend 1990; 26: 145–154.

  22. 22.

    , , , , , et al. Psychiatric safety of ketamine in psychopharmacology research. Psychopharmacology 2007; 192: 253–260.

  23. 23.

    , , , , , . Therapeutic infusions of ketamine: Do the psychoactive effects matter? Drug Alcohol Depend 2014; 136: 153–157.

  24. 24.

    . Stahl’s Essential Psvchopharmacoloav: Neuroscientific Basis and Clinical Applications. Cambridge University Press: New York, NY, USA, 2008.

  25. 25.

    , , . Adverse reactions to ketamine anesthesia: abolition by psychological technique. Anesthesia 1981; 36: 183–187.

  26. 26.

    , , , , , et al. Measurement of dissociative states with the Clinician Administered Dissociative States Scale (CADSS). J Trauma Stress 1998; 11: 125–136.

  27. 27.

    SAS Inc. SAS. Cary, NC. 2003.

  28. 28.

    , , , , . Using self-report assessment methods to explore facets of mindfulness. Assessment 2006; 13: 27–45.

  29. 29.

    , , , . Circuitry of self-control and its role in reducing addiction. Trends Cogn Sci (e-pub ahead of print 13 July 2015).

  30. 30.

    , , , . Withdrawal from acute amphetamine induces an amygdala-driven attenuation of dopamine neuron activity: reversal by ketamine. Neuropsychopharmacology 2015; 41: 619–627.

  31. 31.

    , , , , . mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats. Behav Brain Res 2013; 247: 9–16.

  32. 32.

    , , , , , et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010; 20: 959–964.

  33. 33.

    , . Ketamine psychedelic therapy (KPT): a review of the results of ten years of research. J Psychoactive Drugs 1997; 29: 165–183.

  34. 34.

    , , , , . Typology of club drug use among young adults recruited using time-space sampling. Drug Alcohol Depend 2010; 107: 119–127.

  35. 35.

    , , , , , et al. Ketamine safety and tolerability in clinical trials for treatment-resistant depression. J Clin Psychiatry 2015; 76: 247–252.

  36. 36.

    , . Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug Alcohol Depend 2009; 105: S14–S25.

  37. 37.

    , . The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci 2010; 11: 642–651.

  38. 38.

    , , , , . Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds. Annu Rev Pharmacol Toxicol 2014; 54: 119–139.

  39. 39.

    , , . Relapse prevention. An overview of Marlatt's cognitive-behavioral model. Alcohol Res Health 1999; 23: 151–160.

Download references

Acknowledgements

We thank NIDA for funding this study through grants DA035472 and DA031771 awarded to Dr Dakwar. We also thank the New York State Psychiatric Institute for salary support and the provision of resources.

Author information

Affiliations

  1. New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, New York, NY, USA

    • E Dakwar
    • , C L Hart
    • , F R Levin
    • , E V Nunes
    •  & R W Foltin
  2. Department of Psychology, Columbia University, New York, NY, USA

    • C L Hart

Authors

  1. Search for E Dakwar in:

  2. Search for C L Hart in:

  3. Search for F R Levin in:

  4. Search for E V Nunes in:

  5. Search for R W Foltin in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to E Dakwar.

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/mp.2016.39